Skip to main content

Table 3 Comparison of GBC with and without PBM

From: Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study

 

With PBM

Without PBM

p

(n = 8)

(n = 18)

Age, mean ± SD, years

64.6 ± 11.6

74.7 ± 9.27

0.032

Sex, male, n (%)

1 (12.5)

7 (38.9)

0.36

Gallstones, n (%)

0

10 (55.6)

0.076

Smoking, n (%)a

1 (20)

2 (11.7)

0.558

Histological type

  

0.71

 pap, n (%)

4 (50)

5 (27.8)

 

 tub1, n (%)

2 (25)

7 (38.9)

 

 tub2, n (%)

1 (12.5)

4 (22.2)

 

 Poor, n (%)

1 (12.5)

2 (11.1)

 

T factor

  

0.1

 T1, n (%)

4 (50)

3 (16.6)

 

 T2, n (%)

4 (50)

10 (55.6)

 

 T3, n (%)

0

5 (27.8)

 

Lymph node metastasis, n (%)

2 (25)

7 (38.9)

0.667

TP53 mutations, n (%)

6 (75)

5 (27.8)

0.038

Number of actionable genes, n (%)

3 (37)

12 (66.7)

0.164

  1. GBC Gallbladder carcinoma, PBM Pancreaticobiliary maljunction
  2. aSamples with unknown data were excluded
  3. p values were calculated using Mann–Whitney U test, Fisher’s exact test, and chi-square test